Daily non-political popular news in brief.

Cancer-fighting virus shows promise in early clinical trial

A virus that has been specifically designed by scientists to be safe to normal tissue but deadly to cancer is showing early promise in a preliminary study, researchers said today at the ESMO Conference Lugano (ECLU), Switzerland, 5-8 July 2007.

Read more »

Keywords: cancer-fighting, virus, shows, promise, clinical, trial, cancer, fighting, viru, show

« Previous | Next »

Similar news on "Cancer-fighting virus shows promise in early clinical trial":

1. UCSF brain tumor vaccine trial shows promising results
   04-16-2007 · EurekAlert!
   A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain has shown promise in preliminary data from a clinical trial at the University of California, San Francisco.
   Similar news · Read more »
   
2. Study finds lapatinib shows promise as therapy for inflammatory breast cancer
   12-14-2006 · EurekAlert!
   In the first multi-center clinical trial conducted to better understand the complexities of a rare, aggressive and often lethal form of breast cancer, researchers have discovered that the experimental biological agent, lapatinib, successfully and specifically treats inflammatory breast cancer (IBC).
   Similar news · Read more »
   
3. VEGF Trap shows activity in patients with advanced ovarian cancer
   06-02-2007 · EurekAlert!
   Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents. The findings, which are being presented today at the American Society of Clinical Oncology’s annual meeting, may indicate a role for this targeted therapy in women with ovarian cancer who have exhausted all other options.
   Similar news · Read more »
   
4. Minimally invasive device shows promise in treating female urinary incontinence
   05-22-2007 · EurekAlert!
   A minimally invasive device for treating recurrent stress urinary incontinence in women has been shown to be safe and effective in early clinical trials and is now under review by the US Food and Drug Administration (FDA), says Emory University School of Medicine urologist and trial co-principal investigator Niall Galloway, MD.
   Similar news · Read more »
   
5. New statistical technique shows more informative picture of survival
   01-08-2008 · EurekAlert!
   Researchers have developed a new method for presenting clinical trial survival data that includes data from all trial participants unlike the standard method, according to a commentary published online Jan. 8 in the Journal of the National Cancer Institute.
   Similar news · Read more »
   
6. New drug combination shows promise for African sleeping sickness
   11-06-2007 · EurekAlert!
   A small clinical trial in Uganda, conducted within a long-established Medecins Sans Frontieres treatment program for African sleeping sickness, has found that a new combination treatment using the drugs nifurtimox and eflornithine holds promise and deserves further evaluation. Despite the low sample size, the findings were promising: no cases of treatment failure, no treatment terminations, and no HAT- or treatment-related deaths.
   Similar news · Read more »
   
7. New angiogenesis inhibitor has promise for treating deadly brain tumor
   01-16-2007 · EurekAlert!
   Researchers from the Massachusetts General Hospital Cancer Center have found that AZD2171, a new angiogenesis inhibitor, can significantly reduce the size of the deadly brain tumors called glioblastomas and has the potential of improving the effectiveness of other therapeutic techniques. The Phase 2 clinical trial also finds that the new drug can alleviate brain swelling (edema), a debilitating symptom in many brain cancer patients that currently can be treated only with steroid drugs.
   Similar news · Read more »
   
8. First antisense drug provides benefit to subset of chronic lymphocytic leukemia patients
   02-14-2007 · EurekAlert!
   The first "antisense" drug to be tested in chronic lymphocytic leukemia (CLL) shows benefit in a phase III clinical trial for a specific subset of patients - those who are still sensitive to a chemotherapy drug often used to treat this cancer.
   Similar news · Read more »
   
9. New drug shows promise in treatment of advanced thyroid cancer
   06-04-2007 · EurekAlert!
   The investigational drug axitinib produced tumor regression or stable disease in almost three-out-of-four patients with advanced thyroid cancer, a research team reported June 3 at the annual meeting of the American Society for Clinical Oncology in Chicago.
   Similar news · Read more »
   
10. Other highlights in the November 1 JNCI
    10-31-2006 · EurekAlert!
    Other highlights in the November 1 issue of JNCI include a review of statins and fibrates for action against melanoma, a study of a virus that kills brain tumors in mice, an antibody that decreases ovarian cancer growth in mice and a study that describes the use of the immunohistochemical assay in predicting clinical trial results for breast cancer patients.
    Similar news · Read more »